Canyon Capital Advisors’ Recent Moves Include DHT Holdings Inc (DHT), Cumulus Media Inc (CMLS) & Others

Joshua Friedman and Mitchell Julis’ Canyon Capital Advisors has reported adding DHT Holdings Inc (NYSE:DHT) to its equity portfolio. Canyon Capital Advisors currently holds around 1.83 million shares of the company, which represent 9.64% of the company’s stock.


Earlier in December, Claren Road Asset Management reported initiating a position in DHT Holdings Inc (NYSE:DHT), which contained 3.5 million shares.

Also, recently Canyon Capital Advisors has decreased its position in Cumulus Media Inc (NASDAQ:CMLSto 13.33 million shares, down from 19.63 million held earlier. The current stake amasses 7.04% of the Cumulus Media’s common stock. Cumulus Media, stood on the first spot in Canyon Capital’s equity portfolio at the end of the third quarter in terms of value.

Canyon Capital Advisors raised its holdings in Clear Channel Outdoor Holdings, Inc. (NYSE:CCO) to 5.55 million shares from 5.20 million shares held earlier. In this way, following the increase, the fund’s position amasses 12.74% of the Clear Channel’s common stock.

Canyon Capital Advisors also revealed initiating a 3.04% stake in Capmark Financial Group Inc. (OTCMKTS:CPMK). The position amasses 3.04 million shares.

Joshua Friedman and Mitchell Julis’ fund disclosed a new stake in Ares Commercial Real Estate Corp (NYSE:ACRE). The stake contains around 562,900 shares, equal to1.98% of the Ares’ common stock.

Canyon Capital Advisors is an alternative asset management company that focuses on earning more than debt and equity market indices, with low volatility.

Canyon Capital Advisors holds a significant stake in  Apple Inc. (NASDAQ:AAPL), the position amassing 100,252 shares at the end of September 2013. It is followed by Berry Plastics Group Inc (NYSE:BERY), in which the fund held 2.25 million shares.

Disclosure: none

Recommended reading:

Lone Pine Capital Discloses New 6.4% Stake in LPL Financial Holdings Inc (LPLA)

Royce & Associates Top Picks: Thor Industries Inc. (THO), Reliance Steel & Aluminum (RS) & More

Icahn Discussed: Share Buyback Proposal Unnecessary

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!